Viveve Medical, Inc. (NASDAQ:VIVE) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 870,614 shares, a growth of 42.3% from the May 15th total of 611,984 shares. Based on an average daily trading volume, of 184,207 shares, the short-interest ratio is currently 4.7 days. Currently, 6.3% of the company’s stock are short sold.
Shares of Viveve Medical (VIVE) opened at 7.90 on Friday. The stock’s market capitalization is $152.90 million. The firm’s 50-day moving average price is $7.66 and its 200-day moving average price is $5.97. Viveve Medical has a one year low of $3.75 and a one year high of $11.16.
Viveve Medical (NASDAQ:VIVE) last announced its earnings results on Thursday, May 11th. The company reported ($0.57) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.06. The business had revenue of $3.04 million for the quarter, compared to analyst estimates of $2.70 million. Viveve Medical had a negative net margin of 255.11% and a negative return on equity of 232.94%. Equities research analysts anticipate that Viveve Medical will post ($1.81) EPS for the current fiscal year.
Several hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in shares of Viveve Medical by 924.4% in the first quarter. Vanguard Group Inc. now owns 191,230 shares of the company’s stock valued at $1,210,000 after buying an additional 172,562 shares in the last quarter. EcoR1 Capital LLC acquired a new stake in shares of Viveve Medical during the first quarter valued at $1,583,000. Granahan Investment Management Inc. MA increased its stake in shares of Viveve Medical by 8.0% in the first quarter. Granahan Investment Management Inc. MA now owns 396,494 shares of the company’s stock valued at $2,510,000 after buying an additional 29,364 shares in the last quarter. Wexford Capital LP increased its stake in shares of Viveve Medical by 23.9% in the first quarter. Wexford Capital LP now owns 777,124 shares of the company’s stock valued at $4,919,000 after buying an additional 150,000 shares in the last quarter. Finally, RTW Investments LLC increased its stake in shares of Viveve Medical by 3.0% in the third quarter. RTW Investments LLC now owns 839,274 shares of the company’s stock valued at $6,060,000 after buying an additional 24,328 shares in the last quarter. Institutional investors own 61.19% of the company’s stock.
A number of analysts have issued reports on the company. B. Riley reaffirmed a “buy” rating and set a $10.00 price target on shares of Viveve Medical in a report on Friday, May 12th. ValuEngine raised Viveve Medical from a “sell” rating to a “hold” rating in a report on Friday, June 9th. Raymond James Financial, Inc. assumed coverage on Viveve Medical in a report on Thursday, May 25th. They set an “outperform” rating and a $10.00 price target for the company. Finally, Cowen and Company assumed coverage on Viveve Medical in a report on Wednesday, May 3rd. They set an “outperform” rating and a $11.00 price target for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $12.80.
WARNING: “Viveve Medical, Inc. (VIVE) Short Interest Update” was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.wkrb13.com/markets/2231170/viveve-medical-inc-vive-short-interest-update.html.
Viveve Medical Company Profile
Viveve Medical, Inc designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2231170/viveve-medical-inc-vive-short-interest-update.html
Receive News & Ratings for Viveve Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.